Matthew Dahl, MD
Otolaryngology · Salt Lake City, UTNPI 1679666556
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,255 of the $11,541 with a category attached, or 71.5%. 18 manufacturers reported payments, led by Genentech USA, Inc. at 52.3% of the total. Reporting peaked in 2020 at $6,225 and has fallen 96.0% since, to $252 in 2025. Among otolaryngology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 60 payments — averaging $192.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$6K
- Ambu Inc.$4K
- Stryker$443
- Sanofi$396
- Optinose US, Inc.$128
- GSK$110
- plus $427 from 12 others
What the payments were for
- Consulting fees$8,25572%
- Travel & lodging$1,48913%
- Food & beverage$1,79716%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 6 | $6,037 |
| Ambu Inc. | 1 | $4,000 |
| Stryker | 4 | $443 |
| Sanofi | 15 | $396 |
| Optinose US, Inc. | 8 | $128 |
| GSK | 7 | $110 |
| Smith+Nephew | 3 | $100 |
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
| Intersect ENT, Inc. | 2 | $42 |
| Merck | 2 | $39 |
| Medtronic | 2 | $29 |
| Biocryst US Sales Co., LLC | 1 | $27 |
| Integra Lifesciences Corporation | 1 | $24 |
| AbbVie | 1 | $20 |
| Aerin Medical Inc. | 1 | $20 |
| Dilon Technologies, Inc. | 1 | $19 |
| Acclarent, Inc | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XOLAIR$5,995
- SPIROX - LATERA$226
- NAV - NEW PRODUCT DEVELOPMENT$139
How this compares
$11,541 in reported general payments places this provider in the 95th percentile of 104 otolaryngology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 34 | $1,142 |
| Ofloxacin | 11 | $578 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $181 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Salt Lake City
- Steven MillerSalt Lake City$32K
- Michael WilsonSalt Lake City$16K
- Anthony SanchezSalt Lake City$7K
- Pramod SharmaSalt Lake City$5K
- Joshua BradleySalt Lake City$3K
- Allison DurhamSalt Lake City$3K
- Cory FulcherSalt Lake City$3K
- Mitchell DunklebargerSalt Lake City$2K
- Daniel BestourousSalt Lake City$2K
- John BennettSalt Lake City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.